Overview

Study Evaluating Drug Interaction Between Multiple Doses of Ketoconazole and a Single Dose of SKI-606

Status:
Completed
Trial end date:
2007-03-01
Target enrollment:
Participant gender:
Summary
To investigate a potential pharmacokinetic interaction between SKI-606 and ketoconazole when co-administered.
Phase:
Phase 1
Details
Lead Sponsor:
Wyeth is now a wholly owned subsidiary of Pfizer
Treatments:
Ketoconazole